ALACRITA Trademark

Trademark Overview


On Thursday, March 1, 2012, a trademark application was filed for ALACRITA with the United States Patent and Trademark Office. The USPTO has given the ALACRITA trademark a serial number of 85557129. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, June 30, 2023. This trademark is owned by Alacrita LLP. The ALACRITA trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, and Computer & Software Services & Scientific Services categories with the following description:

Financial advice for companies in the fields of pharmaceuticals, biotechnology, life sciences, medical products, medical devices and healthcare industries; arranging funding, namely, providing financing services, investment consultancy; information, consultancy and advice relating to any of the aforesaid services

Business and market research; business analysis, business planning, business management and business strategy, namely, strategic planning services, strategy development services and business consultancy in the fields of pharmaceuticals, biotechnology, life sciences, medical products, medical devices and healthcare industries; business advice regarding the development and commercialization of products in the fields of pharmaceuticals, biotechnology, life sciences, medical products, medical devices and healthcare industries; recruitment and personnel services, namely, personnel placement; tax services, namely, tax consultation and accountancy services; advertising and promotional services; arranging business networking meeting opportunities for businesses to meet potential investors and to promote their products; information, consultancy and advice relating to any of the aforesaid services; management of clinical trials for drugs, vaccines, diagnostic reagents, small molecules, medical d...

Research in the field of pharmaceuticals, biotechnology, life sciences, medical products, medical devices and scientific research in the field of healthcare industries; clinical research, namely, managing clinical trials for others, providing medical and scientific research information in the field of clinical trials; testing of pharmaceuticals, diagnostic reagents or medical products; conducting of clinical trials for others for drugs, vaccines, diagnostic reagents, small molecules, medical devices; providing scientific information, namely, preparation of reports on clinical trials of drugs, vaccines, diagnostics, small molecules, cellular therapies, medical devices, and research reagents; scientific research, namely, writing of medical research and scientific research-related documents and preparing reports on medical research and scientific research-related documents; testing the safety of pharmaceuticals, vaccines, diagnostic reagents, small molecules, cellular therapies, and medic...
alacrita

General Information


Serial Number85557129
Word MarkALACRITA
Filing DateThursday, March 1, 2012
Status800 - REGISTERED AND RENEWED
Status DateFriday, June 30, 2023
Registration Number4256669
Registration DateTuesday, December 11, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 25, 2012

Trademark Statements


Goods and ServicesFinancial advice for companies in the fields of pharmaceuticals, biotechnology, life sciences, medical products, medical devices and healthcare industries; arranging funding, namely, providing financing services, investment consultancy; information, consultancy and advice relating to any of the aforesaid services
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesBusiness and market research; business analysis, business planning, business management and business strategy, namely, strategic planning services, strategy development services and business consultancy in the fields of pharmaceuticals, biotechnology, life sciences, medical products, medical devices and healthcare industries; business advice regarding the development and commercialization of products in the fields of pharmaceuticals, biotechnology, life sciences, medical products, medical devices and healthcare industries; recruitment and personnel services, namely, personnel placement; tax services, namely, tax consultation and accountancy services; advertising and promotional services; arranging business networking meeting opportunities for businesses to meet potential investors and to promote their products; information, consultancy and advice relating to any of the aforesaid services; management of clinical trials for drugs, vaccines, diagnostic reagents, small molecules, medical devices, namely, providing information management services, providing clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and application for drug approval, or providing independent reviews of clinical trials for business purposes; preparation of reports on clinical trials of drugs, vaccines, diagnostic reagents, small molecules, and medical devices, namely, providing information, management and compilation of computerized databases in the field of clinical trials for business purposes; preparing technical business or financial reports on clinical trials of drugs, vaccines, diagnostic reagents, small molecules, medical devices, preparation of reports on clinical trials of drugs, vaccines, diagnostic reagents, small molecules, and medical devices
Goods and ServicesResearch in the field of pharmaceuticals, biotechnology, life sciences, medical products, medical devices and scientific research in the field of healthcare industries; clinical research, namely, managing clinical trials for others, providing medical and scientific research information in the field of clinical trials; testing of pharmaceuticals, diagnostic reagents or medical products; conducting of clinical trials for others for drugs, vaccines, diagnostic reagents, small molecules, medical devices; providing scientific information, namely, preparation of reports on clinical trials of drugs, vaccines, diagnostics, small molecules, cellular therapies, medical devices, and research reagents; scientific research, namely, writing of medical research and scientific research-related documents and preparing reports on medical research and scientific research-related documents; testing the safety of pharmaceuticals, vaccines, diagnostic reagents, small molecules, cellular therapies, and medical devices, and information, consultancy and advice relating to any of the aforesaid services; consultancy, advice and information in the field of development of drugs, vaccines, diagnostic reagents, small molecules, and medical devices

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, March 8, 2012
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, March 8, 2012
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 8, 2012
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameALACRITA HOLDINGS LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressLONDON NW10NH
GB

Party NameAlacrita LLP
Party Type30 - Original Registrant
Legal Entity Type21 - NOT AVAILABLE
AddressLondon NW10NH
GB

Party NameAlacrita LLP
Party Type20 - Owner at Publication
Legal Entity Type21 - NOT AVAILABLE
AddressLondon NW10NH
GB

Party NameAlacrita LLP
Party Type10 - Original Applicant
Legal Entity Type21 - NOT AVAILABLE
AddressLondon NW10NH
GB

Trademark Events


Event DateEvent Description
Saturday, July 1, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, June 30, 2023REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, June 30, 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, June 30, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, December 6, 2022TEAS SECTION 8 & 9 RECEIVED
Saturday, December 11, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Sunday, November 15, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sunday, November 15, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, November 15, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sunday, November 15, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, November 15, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, November 15, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, December 8, 2018NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Saturday, December 8, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED
Saturday, December 8, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, December 3, 2018TEAS SECTION 8 RECEIVED
Monday, December 11, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, May 24, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, March 19, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 11, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, September 25, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 25, 2012PUBLISHED FOR OPPOSITION
Wednesday, September 5, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 22, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 22, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 22, 2012EXAMINER'S AMENDMENT ENTERED
Wednesday, August 22, 2012NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, August 22, 2012EXAMINERS AMENDMENT E-MAILED
Wednesday, August 22, 2012EXAMINERS AMENDMENT -WRITTEN
Thursday, August 16, 2012AMENDMENT FROM APPLICANT ENTERED
Thursday, August 16, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 14, 2012FAX RECEIVED
Tuesday, July 31, 2012NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, July 31, 2012FINAL REFUSAL E-MAILED
Tuesday, July 31, 2012FINAL REFUSAL WRITTEN
Thursday, July 12, 2012AMENDMENT FROM APPLICANT ENTERED
Thursday, July 12, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 12, 2012ASSIGNED TO LIE
Monday, July 2, 2012FAX RECEIVED
Tuesday, June 19, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 19, 2012NON-FINAL ACTION E-MAILED
Tuesday, June 19, 2012NON-FINAL ACTION WRITTEN
Tuesday, June 12, 2012ASSIGNED TO EXAMINER
Thursday, March 8, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 5, 2012NEW APPLICATION ENTERED